{"id":"NCT00559585","sponsor":"Bristol-Myers Squibb","briefTitle":"Methotrexate-Inadequate Response Study","officialTitle":"A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-11","completion":"2014-09","firstPosted":"2007-11-16","resultsPosted":"2011-07-06","lastUpdate":"2015-11-09"},"enrollment":2492,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis (RA)"],"interventions":[{"type":"DRUG","name":"Subcutaneous (SC) Abatacept","otherNames":["Orencia","BMS-188667"]},{"type":"DRUG","name":"Intravenous (IV) Abatacept","otherNames":["Orencia","BMS-188667"]}],"arms":[{"label":"Subcutaneous (SC) Abatacept","type":"ACTIVE_COMPARATOR"},{"label":"Intravenous (IV) Abatacept","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether a weekly subcutaneous dose of abatacept yields clinical efficacy comparable to that of monthly intravenous doses of abatacept in participants with rheumatoid arthritis and an inadequate response to current methotrexate therapy.","primaryOutcome":{"measure":"Double-blind Period: Number of Participants Achieving American College of Rheumatology (ACR) 20 Response at Day 169","timeFrame":"Day 169","effectByArm":[{"arm":"Subcutaneous Abatacept","deltaMin":527,"sd":null},{"arm":"Intravenous Abatacept","deltaMin":514,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":203,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","France","Germany","Greece","Hungary","India","Ireland","Italy","Mexico","Netherlands","Peru","Poland","Russia","South Africa","South Korea","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["27229685","24584926","21618201"],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":206,"n":731},"commonTop":["Nasopharyngitis","Urinary tract infection","Upper respiratory tract infection","Bronchitis","Diarrhoea"]}}